Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gluco-Max: Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake
NCT06556277Completed
- Start
- Sep 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity and Overweight comparing Metyrapone And Hydrocortisone with Placebo (2 arms). Primary endpoint: Total body fat at 7 days. Started Sep 2024; status: completed.
02
Drugs
metyraponehydrocortisone
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT06556277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06556277.